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Abstract
Background: Immigrants from countries with high incidence of tuberculosis (TB) are usually offered screening
when they arrive to low incidence countries. The tuberculin skin test (TST) is often used. The interferon gamma
release assays (IGRAs) are more specific and not affected by BCG vaccination. The aims of this study were 1. To see
if there if there is a correlation between a positive IGRA (QFT) and presence of a BCG scar in children with TST
≥10 mm, 2. To compare the TST diameter with QFT result, 3. To see if chest X-ray can be omitted in QFT negative
children despite TST ≥10 mm.
Methods: 762 healthy children/adolescents (median age 14 years) arriving to Gothenburg and surroundings with
TST ≥10 mm were tested with QFT.
Results: A total of 163/492 (33 %) children with BCG scar had positive QFT, whereas 205/270 (76 %) without BCG
scar had positive QFT (p < 0.0001). The median TST was 12 mm in QFT negative and 18 mm in QFT positive
children (p < 0.0001) but with considerable overlap. Median TST was the same (12 mm) in QFT negative children
with and without BCG scar. Among the QFT positive children 25/368 had chest X-ray changes compared to 2/393
among the QFT negative children (p < 0.0007).
Conclusions: Previous BCG vaccination had an effect on the TST diameter so an IGRA is recommended to
diagnose latent TB. Using only TST for screening of latent TB would lead to overdiagnosis. The TST diameter was
larger in QFT positive than in QFT negative children but could not predict QFT in the individual patient. Chest X ray
contributes little to the diagnosis of TB in QFT negative children but can not be omitted because of late
seroconversion of QFT in some patients.
Trial registration: Not applicable.
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Background
Immigrants from countries with high incidence of
tuberculosis (TB) are offered medical examination
and screening for TB and other infectious diseases
when they arrive to Sweden. The screening for TB
consisted until recently of physical examination and
a tuberculin skin test (TST). If TST was ≥ 10 mm a
chest X ray was performed. If there were no signs of
active TB, preventive chemotherapy was recom-
mended to children and adolescents (in the following
called children) if compliance could be expected to
be good. From 2007 children coming to the Gothenburg
area with TST ≥10 mm, irrespective if a BCG scar
was visible or not, were referred to clinics specialis-
ing in TB where Quantiferon was assayed. Preventive
chemotherapy was offered if Quantiferon was posi-
tive. The TST limit of 10 mm follows the recom-
mendations of the National Board of Health and
Welfare.
TST is not ideal for screening for latent TB. It re-
quires two visits and it crossreacts with antigens in
the Bacillus Calmette-Guérin (BCG) vaccine and with
many nontuberculous mycobacteria (NTM) [1–8].
Repeated testing can induce false positive results.
Furthermore, the definition of a positive test varies
from 5 to 15 mm) [1–8]. The US Centers for Disease
Control and Prevention adjust for underlying diseases,
history of vaccination and origin of the immigrant
(http://www.cdc.gov/tb/publications/factsheets/testing/
skintesting.htm). In the UK, 5 mm is used as cut-off
in children with BCG scar (National Institure for
Health and Care Excellence, https://www.nice.org.uk/
guidance/ng33/chapter/ recommendations#diagnosing-
latent-tb-in-children-and-young-people).
The interferon gamma release assays (IGRAs) solve
many, but not all, problems in the evaluation of latent TB.
They require only one visit, do not cross-react with BCG
vaccines and cross-react with fewer NTM than TST.
Several studies have shown a rather good correlation
between TST and IGRAs except in very young children
[9–13] but a recent study in 126 adults showed a
relatively poor correlation between TST and IGRAs
and also between two IGRAs (QuantiFERON -TB
Gold In-Tube® (QFT) and T-SPOT.TB®) [12]. The
use of IGRAs is therefore controversial and has not
replaced TST for diagnosis of latent TB in many
countries [14, 15].
It is usually difficult to obtain a reliable vaccination
history from the accompanying adult family member
and impossible if the child arrives alone to Sweden. The
only way to obtain information about BCG vaccination
is to look for typical BCG scars even though BCG
vaccination does not always result in a scar and scars
can wane with time [1, 16–18].
Methods
The aim of the study
The three questions in the present study were; 1. Is there
a correlation between presence of a BCG scar and posi-
tive QFT? (The presence of a BCG scar was in the ab-
sence of documented BCG vaccination used as a
substitute for vaccination), 2. Does the size of the TST
differ between children with positive and negative QFT? 3.
Can chest X ray be omitted in children with negative
QFT, as has been suggested for adults [12]?
Study design and setting
The study is a retrospective evaluation of patient records
of immigrant children who had undergone health exam-
ination and been found to have TST ≥10 mm. The initial
health examination including TST of immigrant children
in the area is performed at several Primary Health
Clinics. Children with TST ≥10 mm are referred to the
Departments of Pediatrics of Sahlgrenska University
Hospital or the outpatient clinics in Angered (north-east
Gothenburg), Borås or Alingsås (all serving surrounding
communities). A chest X-ray is performed. The study in-
cluded children examined from December 2007 through
May 2016. The inclusion criteria in the study were 1)
TST ≥10 mm, 2) No clinical symptoms (cough, swollen
lymph nodes, loss of weight and appetite, fatigue, fever)
or findings on physical examination compatible with
active tuberculosis, 3) No known exposure to tubercu-
losis before or after arrival to Sweden. Three children,
who had come to Sweden alone, who told that they had
been treated for many months in their home countries
with medicines which made their urine red (assumed
to be Rifampicin), were not included. One child was
excluded because it had several scars after recent vari-
cella. It was not possible to evaluate if any of these
scars were caused by BCG. There are no reliable statistics
about the number of immigrant children who undergo
health examinations in the area but an estimate indicates
that it is about 600 children (70 % of all immigrant
children) per year increasing the last years (personal
communication: Leif Dotevall, MD, Department of Com-
municable Diseases, Västra Götaland, Sweden).
Patients
A total of 762 children were included in the study. Gender
and age distribution is shown in Table 1. As many as 215
children came alone without an accompanying adult
(Table 1). Most of the unaccompanied minors came from
Somalia (121), Afghanistan (48) and Eritrea (16). These
children were all aged between 11 and 18 years.
Chest X ray was performed in all but one child, whose
mother declined X ray. This child had a scar and was
QFT negative.
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Both arms were inspected for scars compatible with
BCG vaccination. If no scars were found on the arms,
the thighs were inspected except in a few teen-age girls
who refused this. They all said that they had no scars on
the legs, which was accepted as absence of scar. The
evaluation of BCG scar was made before the QFT result
was known. Only four children had written documenta-
tion of BCG vaccination in their home countries. One of
them had no scar and is included among the children
without scar. The other three had a scar. Three children
had scars on the dorsal side of the lower arm and one
on the hip. They were all accompanied by their mothers
who knew that these scars were induced by vaccination
against TB.
The median time in Sweden was 8 (range 0–96)
months when the QFT was performed. All patients
were tested for syphilis, hepatitis B and HIV. No patient
was syphilis or HIV infected. There were 36 children
with chronic diseases (Table 1). The eight HBsAg posi-
tive patients were all asymptomatic and had normal
liver function tests.
The children came from 59 different countries, when
political borders and not ethnicity was considered.
Chechnya and Dagestan was included in Russia and
Kosovo in Serbia. Kurds and Romanis were included in
the countries they came from. The only exception was 23
children from the Ogaden region, Ethiopia, who were
included among Somalians. The largest groups came from
Somalia + Ogaden (349), Afghanistan (77), Iraq (34) and
Eritrea (24). Table 2 shows numbers of children from dif-
ferent regions of the world and the presence of BCG scars.
Tuberculin skin test
0.1 ml containing 2 TU PPD RT 23 (Statens Seruminsti-
tut, Copenhagen, Denmark) was injected intracutaneously
into the dorsal side of the lower arm. The diameter of the
swelling was measured after 72 h. Towards the end of the
study there was a lack of the TST reagents from Statens
Seruminstitut. During that time Tubertest from Sanofi,
Lyon, France was used.
Quantiferon
Blood for QFT was obtained ≥ 2 months after TST was
read. The sampling and analyses were performed with
QuantiFERON®-TB Gold In Tube according to the in-
structions of the manufacturer (Cellestis Ltd., Chadstone,
Victoria, Australia). One mL blood was collected into each
of three different collection tubes, which include Nil Con-
trol tube, TB Antigen tube, and Mitogen (positive control)
tube. The samples were transported to the laboratory
within 16 h. At the laboratory, the collection tubes were
incubated at 37° for 16–20 h and subsequently centrifuged
at 2300 g for 15 min. The concentration of interferon
gamma in the resulting plasma in the tubes was measured
by ELISA and related to a concentration standard. The
absorbance was measured in Vmax Kinetic Microplate
Reader (Molecular Devices, USA) and the optical density
(OD) values were evaluated using the QFT®-TB Gold
Analysis Software version 2.50. According to the producer,
QFT is positive when TB-antigen – Nil is ≥ 0.35 U/mL. In
this study new blood samples were obtained and the
test was repeated when TB-antigen – Nil was 0.35 to ≤
Table 1 Base-line characteristics of the 762 children included in
the study
Boys-girls 458 boys, 304 girls




Median timea spent in Sweden 8 (0–96) months

















aTime (range) when QFT was assayed
Table 2 Frequency of BCG scars
Number with scar/total
number from this region
Proportion
with scar
Somalia 193/349 55 %
Middle East + North Africa 140/190 74 %
Rest of Africa 57/99 58 %
South East Asia 40/49 82 %
Europe 41/50 82 %
China + Taiwan +Mongolia 9/11 82 %
India + Nepal 5/7 71 %
South America 7/7 100 %
Numbers and proportions of children with BCG scar from different parts of
the world
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1.0 U/mL. This was seen in 18 patients. Seventeen of
them were clearly negative in the second test and one
was clearly positive. The results of the second test were
used in the study.
Statistics
Proportions were compared with 2-tailed Fisher’s exact
test using the method of summing small P values and
median values with 2-tailed Mann–Whitney U test.
Results
A total of 762 children fulfilled all inclusion criteria. BCG
scars were found in 492 of them (65 %) (Table 2). Scars
were found in significantly lower proportions in children
from Somalia and the rest of Sub-Saharan Africa (56 %)
than in all other children combined (77 %) (p < 0.0001).
QFT was positive in 163/492 (33 %) children with a
BCG scar and in 205/270 (76 %) without a scar (p <
0.0001). Significant differences were found in children
from Somalia, the Middle East +North Africa, Sub-Saharan
Africa, Southeast Asia, Europe and China. Children from
India and South America were too few for separate calcula-
tions (Table 3). Somalian children with a BCG scar were
significantly more often QFT positive (55 %) than all other
groups combined (22 %) (p < 0.0001). Significant differ-
ences of the same magnitude were found in boys and girls.
Among children with a scar and TST ≥ 10 mm 329/
492 (67 % had negative QFT, while only 65/270 (24 %)
of the children without a scar and TST ≥ 10 mm had
negative QFT (p < 0.0001).
Among children 5 – 9 years 19/58 (33 %) with BCG
scar had positive QFT compared to 28/41 (68 %) chil-
dren without scar (p = 0.0006). A statistical comparison
for children < 5 years of age was not meaningful because
34/36 with scar had negative QFT while one of two
without scar had negative QFT.
Among the 215 unaccompanied children aged 11 –
18 years 131/215 (61 %) had positive Quantiferon com-
pared to 179/383 (47 %) children aged 11–18 years who
came with their families (p = 0.0009). Among those who
came with their families and were aged between 11 and
18 years, the proportion with BCG scars was higher 266/
383 (69 %) than in the unaccompanied children, 113/215
(53 %) (p < 0.0001).
The median TST diameters were significantly higher in
QFT positive than in QFT negative children (p <0.0001)
both in children with and without scar (Table 4). There
was, however, a considerable overlap (Fig. 1). Among the
children with negative QFT, 279 had TST 10–14 mm and
115 had TST ≥ 15 mm.
Chest X ray changes were seen in 25/368 QFT positive
and in 2/394 QFT negative children. The changes consisted
of enlarged hilar or tracheal lymph nodes or mild to moder-
ate inflammatory infiltrates. One QFT negative child (6 year
old boy from Somalia) had a TST just at the cut-off value of
10 mm. No mycobacteria could be isolated from broncho-
alveolar lavage. He had elevated erythrocyte sedimentation
rate (ESR) and C- Reactive Protein Test (CRP). His changes
disappeared after 6 months of antituberculosis treatment
for active TB with initially four drugs. This QFT negative
child became QFT positive after 1.5 years, when he had
finished treatment for active TB. The other QFT negative
child (15 years old boy from Somalia) had a small basal
inflammatory infiltrate. He had both ESR < 15 mm/h and
CRP < 1.0 mg/L on repeated testing. He became QFT posi-
tive after 7 weeks. No mycobacteria were isolated from
bronchoalveolar lavage. He was also treated for active TB
with 4 drugs initially and chest X ray normalised.
Table 3 Relation between BCG scar and outcome of Quantiferon
With scar Without scar
Pos QFT/total number Pos QFT/total number p-value
Somalia 97/193 (50 %) 129/156 (83 %) <0.0001
Middle East + North Africa 34/140 (24 %) 34/50 (68 %) <0.0001
Rest of Africa 17/57 (30 %) 27/42 (64 %) 0.001
South East Asia 10/40 (25 %) 8/9 (89 %) 0.0007
Europe 4/41 (10 %) 4/9 (44 %) 0.0264
China + Taiwan +Mongolia 0/9 (0 %) 2/2 (100 %) 0.0182
India + Nepal 0/5 (0 %) 1/2 (50 %) ns
South America 1/7 (14 %) 0 ns
All boys 90/291 (31 %) 127/167 (76 %) <0.0001
All girls 73/201 (36 %) 78/103 (76 %) <0.0001
ALL CHILDREN 163/492 (33 %) 205/270 (76 %) <0.0001
Positive Quantiferon (number out of total (%) with positive QFT in children with and without scar arriving to Sweden from different parts of the world. All children
had TST ≥10 mm. (p-values refer to comparisons of proportions in children with and without BCG scar in the respective population)
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Bronchoalveolar lavage was performed in 22 of the 25
QFT positive children with X ray changes. Mycobacter-
ium tuberculosis was cultured from one of them. He was
treated as a case of active TB and chest X-ray normal-
ised. The 21 culture-negative children all had normal
ESR and CRP. All of them were treated as active TB and
all had normal chest X ray after 6 months.
Discussion
The most important difficulty in comparing TST and
QFT is due to the absence of a “golden standard” for the
diagnosis of latent TB. Based on theoretical assumptions
a positive QFT is, however, more specific than a large
TST which has no generally approved definition of
“positive” and no positive and negative controls. This
must be kept in mind when the present and a very large
number of comparative studies are evaluated.
The study showed that there is a highly significant
correlation between presence of BCG scar and positive
QFT. The reason for this could not be answered by the
results. The finding that a higher proportion of children
with scar had negative QFT than children without scar
(67 % verus 24 %) speaks in favour of the possibility that
BCG vaccination resulting in a scar influences TST
while the finding of the same TST diameter in QFT
negative children with and without scar speaks against
an effect of BCG scar on TST (12 mm in both groups).
Assuming that a negative QFT makes latent TB un-
likely something else may have induced the large TST of
≥10 mm in many QFT negative children. This could be
infections with NTM, which is unlikely because NTM
would hardly give any difference between children with
and without scar. Another possibility is previous TST
testing with booster effect (of which we could get no
information), which is also unlikely because in low-
income countries with ongoing civil wars, latent TB is
hardly looked for. The difference between children with
and without a BCG scar makes BCG vaccination result-
ing in a scar the most likely possibility, even though the
causes might be multifactorial. This result was unre-
lated to country of origin, gender and to age ≥10 years
and 5–9 years. The great majority of children with a
BCG scar can be assumed to have been vaccinated at birth
or soon afterwards, since the World Health Organisation
recommends BCG vaccination as early as possible. Since
Table 4 TST diameter related to BCG scar and Quantiferon
QFT Negative QFT Positive p - value
With BCG scar 12 (10–27) 17 (10–38) <0.0001
Without BCG scar 12 (10–23) 18 (10–40) <0.0001
Relation between median (range) TST diameter (mm) and QFT result in
children with and without BCG scar and positive and negative Quantiferon
Fig. 1 TST diameters in Quantiferon negative and positive children
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most of the children in the present study were adolescents
the effect of BCG on TST seems to last for several years.
This finding is in contrast with a study of school children
in India stating that TST can be used for survey of TB
irrespective of BCG vaccination [19] and a study from
Spain indicating that BCG can give a false positive TST
result in children <3 years but not in older children [20].
The most likely explanation of our finding is that BCG
vaccination can induce an increase in the TST reaction,
while QFT is unaffected by BCG vaccination [1–8, 20, 21].
The reasons why some children with no scar have
TST ≥10 mm and negative QFT could be that they had
received a vaccination without getting a scar [1, 16–18]
or that the scar had waned with time which according
to a study from India may occur in 30 % after a five
year period [22]. Besides, different BCG vaccines have
different ability to induce a scar [23, 24]. Their TST
might still react with antigens in BCG. Another possi-
bility could be that the children had been infected with
NTM, many of which can induce an increase in TST
without cross-reacting with the antigens in QFT [2–8].
Besides in patients with active TB negative QFT is found in
about 20 % [25, 26]. In the absence of a reference diagnos-
tic method for latent TB, it is not possible to state how
common falsely negative QFT is in patients with latent TB.
The median TST diameter was significantly larger in
QFT positive than in QFT negative children but the
overlap was great, so it is not possible to predict the
result of QFT based on the size of the TST diameter in
the individual case, which agrees with two previous
studies of Turkish adults and of immigrant children
in Norway [27, 28].
A British study of adults, most of them from Asia,
showed that chest X-ray at the port of entry contributed
little or nothing to finding TB cases [12]. The present
study in children agreed only partly with this. Although
chest X ray findings were significantly more common in
QFT positive than in QFT negative children, chest X ray
in only QFT positive children would have led to missed
or delayed diagnosis in two children, who had late QFT
conversions. Besides there were very few children
<5 years. In this age group immunologic tests like IGRA
may not work well.
The study shows that TST with a cut-off value between
positive and negative of 10 mm should not be used alone
for the diagnosis of latent TB. This would have led to an
overdiagnosis of more than two-fold in children with a
BCG scar and of one-third in children without a BCG
scar, in the present study. Considering the costs of
prophylactic medication, side effects and controls of ad-
herence this seems unacceptable. Confirmation with the
more specific IGRA’s seems necessary both in vaccinated
and nonvaccinated children. A Canadian study performed
among North American Indians also concluded that TST
alone is unsatisfactory for diagnosing latent TB in school
children [8]. A two-step procedure with screening using
the less expensive TST followed by an IGRA may be justi-
fiable if compliance of return for reading the TST is high.
A study from the United Kingdom advocates IGRA
without preceding TST [12]. The U.K. study differs in
two respects from the present. The immigrants in the
U.K. study were mainly young adults coming from the
Indian subcontinent and other Asian countries without
civil wars while the patients in the present study were
children and adolescents and > 50 % of them came as
refugees from countries with devastating civil wars
where the exposure may be expected to be high both in
the home country and during the difficult journey to
Europe. QFT alone is, however, not perfect for diagnos-
ing latent or early active TB because of the late sero-
conversion in some patients, as shown in two cases in
the present sttudy. If resources allow and if compliance
for return can be expected to be good, we recommend
that both TST and QFT are performed and that patients
with positive TST and negative QFT are followed with
repeated QFT for at least two years.
The present study can not be used for evaluation of
the efficacy of BCG vaccination in neonates or early in-
fancy but it seems obvious that any vaccine efficacy must
have waned considerably. This was particularly obvious
in Somalians and in unaccompanied minors. Though the
children in this study were not systematically ques-
tionned about their travelling to Sweden a large number
of Somalian and/or unaccompanied minors told spon-
taneously about several months of being hidden by
smugglers in crowded vans, small apartments or tents
where the risk of exposure must have been considerable.
Many had also spent several months in crowded Libyan,
Ethiopian, Turkish and Greek refugee camps. Children
from other countries and children who came with adult
relatives usually had spent less time and lived under better
conditions between leaving the home countries and arrival
to Sweden. Another reason for the higher proportion of
Quantiferon positivity found in children coming alone
or Somalian children could be that these groups had a
lower frequency of BCG scars, so it is possible that the
vaccination protected them during the first years of life.
Conclusions
The study showed a significant relation between presence
of BCG scar with negative QFT. It did not give a definite
answer whether a BCG scar was related to size of TST.
The diagnosis of latent TB in health examinations with no
known exposure should not be based on a large TST alone
but preferably on a combination of TST and QFT. A con-
firmatory IGRA should be performed in patients with large
TST. QFT negative children with large TST should be
repeatedly tested by IGRA. The TST diameter was larger
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in QFT positive than in QFT negative children but could
not be used to predict the QFT result in the individual
patient. Chest X ray contributes very little to the diagnosis
of TB in asymptomatic QFT negative children but should
not be omitted because of the possibility of falsely negative
QFT or late conversion of QFT in some patients.
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